N-[2-chloro-5-(trifluoromethyl)phenyl]-2-[4-[(4-methylphenyl)sulfonylamino]phenyl]sulfanylacetamide
C22H18ClF3N2O3S2 — CID 23101443
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-chloro-5-(trifluoromethyl)phenyl]-2-[4-[(4-methylphenyl)sulfonylamino]phenyl]sulfanylacetamide
N-[2-chloro-5-(trifluoromethyl)phenyl]-2-[4-[(4-methylphenyl)sulfonylamino]phenyl]sulfanylacetamide (PubChem CID 23101443) has the molecular formula C22H18ClF3N2O3S2 and a molecular weight of 514.98 g/mol. Its IUPAC name is N-[2-chloro-5-(trifluoromethyl)phenyl]-2-[4-[(4-methylphenyl)sulfonylamino]phenyl]sulfanylacetamide.
Molecular Properties
| Compound Name | N-[2-chloro-5-(trifluoromethyl)phenyl]-2-[4-[(4-methylphenyl)sulfonylamino]phenyl]sulfanylacetamide |
|---|---|
| PubChem CID | 23101443 |
| Molecular Formula | C22H18ClF3N2O3S2 |
| Molecular Weight | 514.98 g/mol |
| Exact Mass | 514.04 |
| IUPAC Name | N-[2-chloro-5-(trifluoromethyl)phenyl]-2-[4-[(4-methylphenyl)sulfonylamino]phenyl]sulfanylacetamide |
| SMILES | Cc1ccc(S(=O)(=O)Nc2ccc(SCC(=O)Nc3cc(C(F)(F)F)ccc3Cl)cc2)cc1 |
| InChI | InChI=1S/C22H18ClF3N2O3S2/c1-14-2-9-18(10-3-14)33(30,31)28-16-5-7-17(8-6-16)32-13-21(29)27-20-12-15(22(24,25)26)4-11-19(20)23/h2-12,28H,13H2,1H3,(H,27,29) |
| InChIKey | NZBLBYULDIWSQI-UHFFFAOYSA-N |
| XLogP | 6.20 |
| TPSA | 75.27 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 514.98 |
| LogP ≤ 5 | 6.20 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 23101443 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.